Command Palette

Search for a command to run...

dr-agarwals-eye-hospital

5039.05-1.15%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Institution
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Dr Agarwals Eye Hospital Ltd. is currently positioned in a competitive landscape with significant peers showing strong financial metrics. While Dr Agarwals struggles with growth and profitability metrics, peers like Max Healthcare Institute and Apollo Hospitals demonstrate robust growth, profitability, and efficiency. Strategic value picks exist in Aster DM Healthcare and Fortis Healthcare despite their challenges in profitability, making them potentially attractive for investors seeking value at lower valuations.

Key Points
  • Dr Agarwals Eye Hospital shows no growth in revenue or profitability metrics, a cause for concern.
  • Max Healthcare and Apollo Hospitals lead in growth, EPS, and profitability with solid ROE and EBITDA margins.
  • Aster DM Healthcare presents as a deep value pick due to low PE and PBV ratios despite negative revenue growth.
  • Fortis Healthcare, while high in PE, has low debt and a decent EBITDA margin, but significantly low profitability metrics raise concerns.
Top Performers
Max Healthcare Institute Ltd.

Highest revenue growth (YoY: 18.49%) and strong profitability metrics (ROE: 13.47%).

Apollo Hospitals Enterprise Ltd.

Solid EPS growth (100.56), high ROE (20.51), and decent revenue growth (14.73%).

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.